Owen Hughes
Pharmaceutical Sciences
Malin
Ireland
Biography
Owen Hughes currently serves as the Chief Business Officer and Head of Corporate Development at Intarcia Therapeutics, a late stage diabetes company and as a Director of Radius Health, a Phase 3 osteoporosis company. Prior to Intarcia, Mr. Hughes served as a Director at Brookside Capital, a multi-billion dollar hedge fund that falls under the Bain Capital umbrella. There, he co-managed public and private healthcare investments including those in the biotechnology, med-tech, and services segments. Mr. Hughes has over 16 years of Wall Street experience on both the buy and sell-side. Owen Hughes currently serves as the Chief Business Officer and Head of Corporate Development at Intarcia Therapeutics, a late stage diabetes company and as a Director of Radius Health, a Phase 3 osteoporosis company. Prior to Intarcia, Mr. Hughes served as a Director at Brookside Capital, a multi-billion dollar hedge fund that falls under the Bain Capital umbrella. There, he co-managed public and private healthcare investments including those in the biotechnology, med-tech, and services segments. Mr. Hughes has over 16 years of Wall Street experience on both the buy and sell-side.
Research Interest
molecular neuroscience
